Emperor’s syndrome in the COVID-19 era:Time for patient-centered nephrology?  

作　　者：Dimitra Bacharaki Athanasios Diamandopoulos 

机构地区：[1]Department of Nephrology,Attikon University Hospital,Chaidari 12462,Greece [2]EKPA,Louros Foundation for the History of Medicine,Chaidari 12462,Greece

出　　处：《World Journal of Nephrology》2021年第1期1-7,共7页世界肾病学杂志（英文版）

摘　　要：The coronavirus disease-19(COVID-19)pandemic has been a wake-up call in which has forced us to react worldwide.Health policies and practices have attracted particular attention in terms of human and financial cost.Before COVID-19,chronic kidney disease was already considered a risk multiplier in patients with diabetes and hypertension,the two now being the major risk factors for COVID-19 infection and adverse outcome.In contrast to the urgent need for action,the nephrology field is considered to be in a state of stagnation regarding the management of chronic kidney disease patients who still experience unacceptably high morbidity and mortality.Ironically and paradoxically in a field lacking robust clinical trials,clinical practice is driven by guidelines-based medicine on weak evidence.The Emperor’s syndrome,referring to Hans Christian Andersen’s fairy tale,has been described in medicine as voluntary blindness to an obvious truth,being a weak evidence-based therapeutic intervention or weak health care.A promising positive example of improving heart and kidney outcomes is the emerging treatment with sodium-glucose cotransporter 2 inhibitors.COVID-19 could boost actions for patient-centered care as a positive shift in nephrology care.

关 键 词：Emperor’s syndrome Chronic kidney disease Guidelines-based medicine Patient-centered care COVID-19 Evidence-based medicine 

分 类 号：R69[医药卫生—泌尿科学]